KMT2D upregulates SMG1 via histone methylation to antagonize mTOR and reinforce DLBCL ferroptosisYongcheng Sun on 27 de June de 2025 at 10:00
J Leukoc Biol. 2025 Jun 19:qiaf092. doi: 10.1093/jleuko/qiaf092. Online ahead of print. ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is highly heterogeneous and prone to epigenetic mutations. Non-apoptotic cell death pathways, especially ferroptosis, have become an emerging direction for cancer treatment. This project was designed to probe into the potential of histone-lysine N-methyltransferase 2D (KMT2D) in … Read more